Astra M Liepa Selected Research

Astra M Liepa Research Topics

Disease

16	Neoplasms (Cancer) 06/2023 - 01/2008
11	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2014
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2004
9	Adenocarcinoma 10/2021 - 11/2009
6	Disease Progression 11/2020 - 06/2005
5	Carcinoma (Carcinomatosis) 11/2020 - 12/2009
4	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2005
4	Pain (Aches) 11/2020 - 03/2012
4	Neutropenia 01/2020 - 08/2004
2	Fatigue 01/2024 - 08/2004
2	Weight Loss (Weight Reduction) 01/2021 - 01/2019
2	Febrile Neutropenia 01/2020 - 08/2004
2	Sepsis (Septicemia) 11/2017 - 03/2010
2	Neoplasm Metastasis (Metastasis) 06/2017 - 01/2014
2	Lung Neoplasms (Lung Cancer) 10/2012 - 01/2008
2	Thrombocytopenia (Thrombopenia) 10/2012 - 03/2010
2	Large Cell Carcinoma 12/2009 - 11/2009
2	Malignant Mesothelioma 01/2006 - 08/2004
1	Diarrhea 01/2024
1	Microsatellite Instability 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 08/2018
1	Vomiting 07/2017
1	Nausea 07/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2012
1	Brain Neoplasms (Brain Tumor) 10/2012
1	Pulmonary Embolism 10/2012
1	Glioblastoma (Glioblastoma Multiforme) 03/2010
1	Panniculitis 03/2010
1	Stroke (Strokes) 03/2010
1	Renal Insufficiency (Renal Failure) 03/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009
1	Mesothelioma 01/2006

Drug/Important Bio-Agent (IBA)

12	RamucirumabIBA 06/2023 - 01/2014
12	PlatinumIBA 10/2021 - 12/2009
12	Pemetrexed (MTA)FDA Link 12/2012 - 08/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2009
6	Gemcitabine FDA Link 03/2016 - 08/2004
4	Docetaxel (Taxotere)FDA Link 11/2020 - 01/2008
4	Cisplatin (Platino)FDA LinkGeneric 10/2010 - 08/2004
3	AntiemeticsIBA 01/2021 - 07/2017
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 01/2014
3	enzastaurinIBA 10/2012 - 03/2010
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2017 - 08/2004
2	AnthracyclinesIBA 03/2016 - 06/2005
2	Carboplatin (JM8)FDA LinkGeneric 12/2012 - 11/2009
1	abemaciclibIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 06/2023
1	LigandsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	HematinicsIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 08/2018
1	Analgesics (Analgesic Drugs)IBA 07/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2017
1	SodiumIBA 06/2017
1	Alkaline PhosphataseIBA 06/2017
1	AlbuminsIBA 06/2017
1	Rituximab (Mabthera)FDA Link 09/2015
1	Monoclonal AntibodiesIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Etoposide (VP 16)FDA LinkGeneric 12/2012
1	Cytotoxins (Cytolysins)IBA 12/2012
1	Protein Kinase CIBA 10/2012
1	Lomustine (CCNU)FDA Link 03/2010
1	Bevacizumab (Avastin)FDA Link 11/2009
1	VitaminsIBA 06/2005
1	Capecitabine (Xeloda)FDA Link 06/2005
1	Taxoids (Taxanes)IBA 06/2005
1	Folic Acid AntagonistsIBA 06/2005
1	taxaneIBA 06/2005
1	Alanine Transaminase (SGPT)IBA 08/2004

Therapy/Procedure

25	Therapeutics 01/2024 - 08/2004
9	Drug Therapy (Chemotherapy) 01/2021 - 08/2004
2	Nutritional Support (Artificial Feeding) 01/2021 - 07/2017
2	Radiotherapy 12/2020 - 10/2012
1	Aftercare (After-Treatment) 01/2024
1	Immunotherapy 01/2023
1	Durable Medical Equipment (Medical Equipment, Durable) 12/2020
1	Neoadjuvant Therapy 03/2016